Skip to content
54

thomapyrin tension duo

Worth a look

Shows low returns (0.0%), but brand-locked demand (top 5 brands take 100% of clicks) keeps it on the watch list.

Market size 54Growth 34Conversion 96Competition 51Returns 100Price range 79Avg price 95Brand share 0Review moat 66Quality gap 20

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible13.3%

search→purchase rate — share of searches ending in a sale

Avg price

Incredible€23.64

avg listing price — sweet spot $15–$100

Price range

Great€7.85–€44.41

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Good864.53

avg incumbent reviews — the moat a new listing must climb

Market size

Good€365K

€365K/yr · 116K searches

Competition

Good55%

top-5 click share — leaders hold, buyers still browse

Growth

Okay+6.9%

90-day search growth — must beat 0% to launch

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products take 55% of clicks — established leaders, but buyers still shop beyond them.

Brands

3 falling

Sellers

25

Top-5 brand share

100%

Open market

0%

  • Thomapyrin89%
  • Bodfeld Apotheke6%
  • vitenda5%

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%5%€18K10%€36K15%€55K20%€73K1101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)1 product missing review or click data not plotted

All 19 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — +6.9% search growth over the last 90 days.
3K2KSpike '24Holiday '24Spike '25Prime Day '25SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.8×